Novocure Limited (NVCR) is rated BUY, driven by expanding regulatory approvals, breakthrough clinical results, and a robust ...

Arcus Biosciences is a 'Buy' with strong trial results, robust pipeline, and key phase 3 news coming. Click here to read an analysis of RCUS stock now.

Energy experts gathered in Raleigh this week to discuss how North Carolina’s energy grid — and ratepayers’ wallets — will ...

Drug candidates spanning oncology, neurology, rare diseases and more are approaching critical development as the calendar turns to 2026.

Today, cutting-edge research and development (R&D) is happening out of India, and it’s happening in our parks,” says Gauri ...

In an arena more and more characterized by smart automation and economic nuance, the impact of AI on business sales has come far from predictive modeling. Today's systems don't predict results; they ...

Utilities are pushing to increase supply, but meeting the surge in demand won’t be easy or fast. Tech companies aren’t ...

Markets near record highs are prompting investors to look to utilities and energy stocks for steady income and long-term ...

PAR Technology Corporation, a leading foodservice technology provider, today announced that Layne’s Chicken Fingers—the Texas “Born and Breaded” chicken finger concept—has selected PAR Engagement to ...

ESTIC-2025 is designed as a translation platform. It brings together government ministries and departments, laboratories and ...

Channel partners say NetApp is on the right track with its talk about transforming data for AI and then making sure it is ...